Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation? ; volume:18 ; number:1 ; day:24 ; month:8 ; year:2020 ; pages:1-5 ; date:12.2020
Thrombosis journal ; 18, Heft 1 (24.8.2020), 1-5, 12.2020
- Creator
-
Giffard-Quillon, Lorine
Desmurs-Clavel, Helene
Grange, Claire
Jourdy, Yohann
Dargaud, Yesim
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-020-00228-9
- URN
-
urn:nbn:de:101:1-2020091021555627784844
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Giffard-Quillon, Lorine
- Desmurs-Clavel, Helene
- Grange, Claire
- Jourdy, Yohann
- Dargaud, Yesim
- SpringerLink (Online service)
Other Objects (12)
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
Human Prothrombin/Phospholipids Interaction. Competitive Effect of an Anticoagulant Venom Phospholipase A2
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
Human Prothrombin/Phospholipids Interaction. Competitive Effect of an Anticoagulant Venom Phospholipase A2
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
Human Prothrombin/Phospholipids Interaction. Competitive Effect of an Anticoagulant Venom Phospholipase A2
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal